V. Daugé

1.6k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

V. Daugé is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, V. Daugé has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in V. Daugé's work include Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). V. Daugé is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). V. Daugé collaborates with scholars based in France, Morocco and United States. V. Daugé's co-authors include B P Roques, M C Fournié-Zaluski, Florence Noble, Ann Beaumont, B.P. Roques, Jean Féger, G. Gacel, P. Rossignol, Muriel Derrien and Stéphane Melik Parsadaniantz and has published in prestigious journals such as Brain Research, Pharmacological Reviews and Annals of the New York Academy of Sciences.

In The Last Decade

V. Daugé

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

1993 647 citations B P Roques, V. Daugé et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Daugé France	15	844	648	333	322	111	25	1.4k
Sophie Gautron France	18	582 0.7×	943 1.5×	171 0.5×	310 1.0×	67 0.6×	31	1.7k
Akira Matsushita Japan	23	552 0.7×	488 0.8×	118 0.4×	310 1.0×	60 0.5×	144	1.6k
Sandra Lechner United States	20	553 0.7×	785 1.2×	280 0.8×	160 0.5×	49 0.4×	27	1.8k
Philipp von Rosenstiel United States	20	307 0.4×	845 1.3×	157 0.5×	325 1.0×	136 1.2×	55	2.4k
Tatsuhide Kunishita Japan	21	296 0.4×	769 1.2×	677 2.0×	166 0.5×	230 2.1×	50	1.9k
Michèle Goodhardt France	26	720 0.9×	1.2k 1.8×	574 1.7×	141 0.4×	143 1.3×	51	2.5k
Frederick Jia‐Pei Miao United States	19	384 0.5×	603 0.9×	647 1.9×	60 0.2×	162 1.5×	36	1.6k
Jerzy Maj Poland	24	806 1.0×	603 0.9×	151 0.5×	110 0.3×	30 0.3×	37	1.6k
Donna Oksenberg United States	22	683 0.8×	914 1.4×	259 0.8×	64 0.2×	108 1.0×	50	2.1k
Yong‐Seok Oh South Korea	22	292 0.3×	884 1.4×	143 0.4×	97 0.3×	85 0.8×	62	1.6k

Countries citing papers authored by V. Daugé

Since Specialization

Citations

This map shows the geographic impact of V. Daugé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Daugé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Daugé more than expected).

Fields of papers citing papers by V. Daugé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Daugé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Daugé. The network helps show where V. Daugé may publish in the future.

Co-authorship network of co-authors of V. Daugé

This figure shows the co-authorship network connecting the top 25 collaborators of V. Daugé. A scholar is included among the top collaborators of V. Daugé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Daugé. V. Daugé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guyon, Alice, Delphine Skrzydelski, Carole Rovère, et al.. (2009). Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience. 162(4). 1072–1080. 93 indexed citations

Skrzydelski, Delphine, Alice Guyon, V. Daugé, et al.. (2007). The chemokine stromal cell‐derived factor‐1/CXCL12 activates the nigrostriatal dopamine system. Journal of Neurochemistry. 102(4). 1175–1183. 73 indexed citations

Daugé, V., et al.. (2003). Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory. Neuroscience. 118(1). 19–23. 10 indexed citations

Taghzouti, Khalid, Isabelle Léna, F. Dellu, et al.. (1999). Cognitive enhancing effects in young and old rats of pBC 264 , a selective CCK B receptor agonist. Psychopharmacology. 143(2). 141–149. 23 indexed citations

Parsadaniantz, Stéphane Melik, V. Daugé, B. P. Roques, & Bernard Kerdelhué. (1999). Acute Intrahippocampal Injection of Human Interleukin-1β Stimulates the Anterior Pituitary POMC Transcription and Increases Plasma Levels of ACTH and Corticosterone in the Male Rat. Neuroendocrinology. 69(2). 77–87. 10 indexed citations

Blanco‐Prieto, María J., C. Durieux, V. Daugé, et al.. (1996). Slow Delivery of the Selective Cholecystokinin Agonist pBC 264 into the Rat Nucleus Accumbens Using Microspheres. Journal of Neurochemistry. 67(6). 2417–2424. 9 indexed citations

Derrien, Muriel, et al.. (1994). The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats. Behavioural Brain Research. 65(2). 139–146. 14 indexed citations

Derrien, Muriel, C. Durieux, V. Daugé, & B.P. Roques. (1993). Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens. Brain Research. 617(2). 181–188. 25 indexed citations

Daugé, V., Muriel Derrien, J.C. Blanchard, & B.P. Roques. (1992). The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats. Neuropharmacology. 31(1). 67–75. 22 indexed citations

10.

Daugé, V., et al.. (1991). Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area. Psychopharmacology. 103(4). 493–502. 58 indexed citations

11.

Baamonde, Ana, V. Daugé, G. Gacel, & B P Roques. (1991). Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 767–773. 29 indexed citations

12.

Maldonado, Rafaël, V. Daugé, Jean Féger, & B.P. Roques. (1990). Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats. Neuropharmacology. 29(3). 215–223. 28 indexed citations

13.

Maldonado, R., Ana Baamonde, V. Daugé, & Jean Féger. (1990). Effects induced by chronic treatment with selective D₁or D₂antagonists on open‐field behavior and colonic temperature. Fundamental and Clinical Pharmacology. 4(3). 341–356. 7 indexed citations

14.

Daugé, V., Georg Andrees Böhme, Jacqueline N. Crawley, et al.. (1990). Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse. 6(1). 73–80. 70 indexed citations

15.

Daugé, V., et al.. (1989). CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens. Pharmacology Biochemistry and Behavior. 34(1). 157–163. 66 indexed citations

16.

Maldonado, Rafaël, V. Daugé, Jacques Callebert, et al.. (1989). Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome. European Journal of Pharmacology. 165(2-3). 199–207. 45 indexed citations

17.

Daugé, V., et al.. (1989). The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. European Journal of Pharmacology. 163(1). 25–32. 23 indexed citations

18.

Daugé, V., et al.. (1988). Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective ? and ? opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes. Psychopharmacology. 96(3). 343–352. 79 indexed citations

19.

Gacel, G., et al.. (1988). Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for .delta. opioid receptors. Journal of Medicinal Chemistry. 31(10). 1891–1897. 43 indexed citations

20.

Roques, B P, C. Durieux, G. Gacel, et al.. (1985). Studies on the Conformation, Enzymatic Degradation, Pharmacological Potency, and Binding Properties in Brain Tissue of Cholecystokinin‐8 and New Related Peptidesa. Annals of the New York Academy of Sciences. 448(1). 61–75. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact